is the amyloid-beta (Aβ) plaque, which could not be detected during life until recently. Advances have permitted its detection in cerebrospinal fluid and with positron emission tomography (PET ...

(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...

This finding suggests that a single positron emission tomography (PET) scan assessing amyloid beta protein levels in the brain could be sufficient to predict the rate of cognitive decline in ...

Taking longer to reach the rapid eye movement (REM) stage of sleep could mean you are more likely to develop dementia.

including both amyloid-beta and tau deposition," they wrote. Lee and colleagues assessed 208 cognitively unimpaired people who had baseline amyloid PET scans; of these, 192 completed both baseline ...

This study adds to the growing evidence that Alzheimer’s disease may start long before traditional symptoms appear. The fact ...

advanced coverage for beta-amyloid PET imaging by removing coverage with evidence development (CED), allowing Medicare to cover amyloid PET scans outside of a research protocol. Change begins with ...

Alzheimer’s disease (AD) is the most common form of dementia in the elderly. Although the prevalence of AD increases with age, studies have indicated that a number of elderly patients have AD ...

Eisai has tackled AD drug discovery for four decades, resulting in a symptomatic breakthrough treatment in the 1980s and the continued development of anti-amyloid and anti-tau antibodies today.